Skip to main content

Table 3 Success and Adverse Event Score in Endoscopic Retrograde Cholangiopancreatography (SASE), regrading of the ASGE complexity grades for ERCP

From: SASE, Success and Adverse event Score in Endoscopic Retrograde Cholangiopancreatography: a Novel Grading System

 

Success

Adverse event

 

Target

Cannu-lation

Overalla

success

Bleeding

PEP

At least one

Overalla

compli-cation

ASGE grading system

Billroth II

neg.

neg.

 

n.s.

n.s.

n.s.

 

neg.

Emergency case (outside normal hours)

n.s.

n.s.

 

n.s.

n.s.

n.s.

 

neg.

Child < 3 years

n.a.

n.a.

 

n.a.

n.a.

n.a.

 

neg.

Previous failed/incomplete procedure

neg.

neg.

 

pos.

n.s.

n.s.

 

neg.

SASE 1/1

Biliary stent removal /exchange

1

1

1

1

1

1

1

1

SASE 1/2

Treat benign biliary strictures hilum and above

1

1

1

1

2

2

2

3

Biliary stone extraction > 10 mm

1

1

1

2

2

2

2

3

Extract internally migrated pancreatic stent

1

1

1

2

2

2

2

4

Intraductal imaging, biopsy

1

1

1

2

2

2

2

3

Manage acute or recurrent pancreatitis

1

1

1

2

2

2

2

3

Remove of internally migrated biliary stents

1

1

1

2

2

2

2

3

Treat biliary leaks

1

1

1

2

2

2

2

2

SASE 1/3

Biliary stone extraction < 10 mm

1

1

1

3

2

3

3

2

Manage suspected sphincter Oddi dysfunction

1

1

1

2

3

3

3

3

Treat extrahepatic benign/malignant strictures

1

1

1

2

3

3

3

2

SASE 2 /2

Deep cannulation of duct of interest, main papilla sampling

2

1

2

2

2

2

2

1

Aspiration of bile

2

2

2

2

2

2

2

1

Intraductal image guided therapy (e.g. PDT; electrohydraulic lithotripsy)

2

1

2

2

2

2

2

4

Intrahepatic stones

2

1

2

2

2

2

2

4

Minor papilla cannulation in p. divisum, & therapy

2

2

2

2

3

2

2

3

Remove pancreatic stones mobile and < 5 mm

2

1

2

2

2

2

2

3

Treat hilar tumors

2

1

2

2

2

2

2

3

Treat pancreatic strictures

2

1

2

1

3

2

2

3

SASE 2/3

Ampullectomy

2

1

2

3

3

3

3

4

Pancreatic stones impacted and/or > 5 mm

3

1

2

2

3

3

3

4

SASE 3/2

ERCP after Whipple or Roux - en - Y

3

2

3

2

2

2

2

4

SASE 3/3

Place prophylactic pancreatic stents

3

2

3

3

3

3

3

2

  1. neg. significant negative OR, corresponding to lower success/adverse event rate
  2. pos. significant positive OR, corresponding to higher success/ adverse event rate
  3. SASE grade 1: high success/low adverse event rate
  4. SASE grade 2: intermediate success/ adverse event rate
  5. SASE grade 3: low success/high adverse event rate
  6. Abbreviations: ERCP, endoscopic retrograde cholangiopancreatography; n.a., not available; n.s., not significant; PDT, photodynamic therapy; PEP, post ERCP pancreatitis.
  7. amedian